$IMAX

HOYTS Cinemas and IMAX expand partnership securing 10 new IMAX with Laser locations across Australia and New Zealand

HOYTS Cinemas and IMAX Corporation agreed to add 10 new IMAX with Laser locations in Australia and New Zealand, expanding their partnership. This deal will increase IMAX's footprint in the region to 14 locations by 2028. Both companies cited strong demand and performance of existing IMAX locations as key drivers. IMAX Australia reported record box office revenue of AUD 18.6 million in 2025.

Original reporting
Published Sep 6, 2026, 1:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 7, 2026, 12:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
HOYTS Cinemas and IMAX expand partnership securing 10 new IMAX with Laser locations across Australia and New Zealand — source image
Decision brief

The 30-second read

$IMAXBullishLow
01

Why it matters

The agreement expands IMAX's global footprint, particularly in a high‑growth region, but the lack of disclosed financial details limits immediate valuation impact.

02

Market read

The deal signals continued demand for premium cinema experiences and may incrementally benefit IMAX's revenue outlook.

03

What to watch

Potential cannibalization of existing IMAX locations and the capital expenditure required for Laser upgrades.

Relevance 6/10Novelty 5/10Timing: announced today

Background

HOYTS is Australia's leading cinema chain; IMAX is a US‑listed provider of premium large‑screen experiences.

Company-level read

Ticker impact

$IMAXBullishMedium confidence
Context

IMAX announced a new agreement with HOYTS to add 10 IMAX with Laser locations in Australia and New Zealand, expanding its footprint to 14 sites.

Expected impact

Modest upside pressure on IMAX shares as investors price in incremental franchise revenue.

Evidence & confidence

The deal adds significant screen count in a strong market, but no financial terms were disclosed, limiting immediate price impact.

Market effects

Strengthens the premium cinema segment and could benefit related content producers.

Boosts Australian entertainment venue outlook.

Highlights IMAX's expansion strategy in international markets.

Counterpoint

Without disclosed financial terms, the partnership may not materially affect earnings.

Key entities

  • HOYTS Cinemas

    Australian cinema chain partnering with IMAX.

  • IMAX Corporation

    US‑listed provider of premium cinema technology.

Related articles

$IMAXMed

IMAX at Bank of America 2026 Media,Communications & Entertainment Conference: global surge

IMAX Corporation (IMAX) reported strong global growth at the Bank of America 2026 Media, Communications & Entertainment Conference. CEO Rich Gelfond highlighted record box office performance, international expansion, and new revenue streams. Current-quarter box office is on track to exceed $600 million, with significant contributions from international markets and local-language films. The company operates 1,800 theaters, with 500 in backlog, and aims to expand further. IMAX is also diversifying

$IMAXMed

Why IMAX Stock Climbed to a New All-Time High Today

IMAX stock reached a new all-time high on Monday, rising 3.89% to $54.79. The surge was driven by the record-breaking success of The Odyssey, which became the highest-grossing IMAX release. CEO Rich Gelfond expects this to be their best year. Analyst Steve Frankel predicts IMAX will exceed estimates in the second half of 2026, with shares potentially rising to $60. The company's Q2 2026 revenue grew 12% to $103 million, with adjusted earnings up 65% to $0.43 per share.

$IMAXMed

“The Odyssey” Demand Drives IMAX Shares Higher

IMAX reported Q2 2026 revenue of $103M (up 12% YoY) and EPS of $0.43 (up 65%), driven by strong demand for 'The Odyssey'. The stock has gained 42% YTD, with institutional inflows contributing to a 103.5% rise over the past year. IMAX shows strong sales and EPS growth rates of 11.7% and 18.7% respectively over three years, with EPS expected to rise 14% this year.

$IMAXMed

Why IMAX Stock Rallied on Monday

IMAX shares rose about 5% on Monday after the company said Christopher Nolan’s film The Odyssey became the highest-grossing IMAX release of all time. IMAX reported $289 million in ticket sales, plus $37 million in the fourth weekend, and said IMAX theaters account for 26% of total tickets. IMAX added that 70mm locations have grossed over $37 million and presales near $40 million.

$IMAXMed

Why IMAX Stock Soared on Monday

IMAX said The Odyssey helped it post its highest-ever monthly box-office results, with July box-office revenue of $257 million, up 47% from the prior record. Ticket sales for The Odyssey totaled $221 million. IMAX also announced an upcoming run for Spider-Man: Brand New Day and shares closed Monday nearly 7% higher.